? Is Inframallolar Angioplasty Effective for Wound Healing in Patients with Critical Lower Limb Ischemia and Tibial Only Disease

Abstract

revalence of PAD is approximately 3–10% in the population as a whole, with this increasing to between 15 and 20% when focusing on older patients (> 70 years of age). Critical limb ischemia is a clinical syndrome defined by the presence of peripheral artery disease (PAD) in combination with rest pain, gangrene, or a lower limb ulceration >2 weeks duration. Critical limb ischemia (CLI) with tissue loss was associated with 4‐year amputation rates of 35% to 67%. The leading cause of hospitalization and amputation in diabetic patients is foot ulcers indeed 20-40% of the healthcare resources spent on diabetes are related to diabetic feet. and mortality rate of 20% within 6 months after the diagnosis and 50% at 5 years. Inframalleolar disease is a serious clinical problem in patients with chronic limb-threatening ischemia (CLTI). It is associated with impaired limb salvage and delayed wound healing among CLTI patients who undergo endovascular treatment (EVT.Pedal arch types were classified into type 1 (both dorsalis pedis and lateral plantar arteries are patent), type 2 (either the dorsalis pedis artery or the lateral plantar artery is patent), type 3 (neither dorsalis pedis artery nor the lateral plantar artery are patent). Percutaneous transluminal angioplasty is increasingly being used as the first line revascularization procedure for treatment of peripheral arterial occlusive disease, even in the most challenging areas such as the infrapopliteal segment, and it has shown encouraging leg salvage rate.